Changing trends in androgen deprivation therapy prescribing for prostate cancer in England, 2015–2024
Journal of Oncology Pharmacy Practice
Published online on April 09, 2026
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
IntroductionGonadotropin-releasing hormone (GnRH) agonists are the most commonly used form of androgen deprivation therapy (ADT) for advanced prostate cancer, often prescribed with radiotherapy or chemotherapy. This study examined national trends in the ...
IntroductionGonadotropin-releasing hormone (GnRH) agonists are the most commonly used form of androgen deprivation therapy (ADT) for advanced prostate cancer, often prescribed with radiotherapy or chemotherapy. This study examined national trends in the ...